At a glance
- Originator Bristol-Myers Squibb
- Class Antineoplastics; Benzoic acids; Retinoids
- Mechanism of Action Retinoic acid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Acne; Cancer; Psoriasis
Most Recent Events
- 16 Sep 1999 New profile
- 16 Sep 1999 Preclinical development for Acne in USA (Unknown route)
- 16 Sep 1999 Preclinical development for Cancer in USA (Unknown route)